Market Place
Sourcing Support
Norgine Announces Appointment of New CEO Janneke van der Kamp
02 Oct 2024 //
PR NEWSWIRE
Norgine Submits MAA For Eflornithine In High-Risk Neuroblastoma
15 Apr 2024 //
PR NEWSWIRE
Norgine receives +ve opinion recommending approval of NPJ5008 for the MH
26 Mar 2024 //
PR NEWSWIRE
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement
18 Mar 2024 //
PR NEWSWIRE
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement
17 Mar 2024 //
GLOBENEWSWIRE
Norgine Strengthens Leadership with Appointment of Saulo Martiniano as COO
11 Sep 2023 //
PR NEWSWIRE
Norgine Announces Closing of Investment from Goldman Sachs Asset Management
15 Dec 2022 //
PRNEWSWIRE
LEO Pharma, Norgine, Daiichi-Sankyo, Novartis, Sanofi, Consilient
02 Aug 2021 //
FIRSTWORDPHARMA
Norgine enter agreement to commercialise DFMO in independent States
23 Jul 2021 //
PRNEWSWIRE
Norgine enter agreement to commercialise DFMO in independent States
23 Jul 2021 //
PRNEWSWIRE
Norgine enter agreement to commercialise DFMO in independent States
23 Jul 2021 //
PRNEWSWIRE
NORGINE B.V. ANNOUNCES NEW EUROPEAN HEALTHCARE SUBSIDIARY
01 Dec 2020 //
COM
AMAG & Norgine B.V. Enter Into Exclusive Licensing Agreement Ciraparantag
23 Jul 2020 //
GLOBENEWSWIRE
Norgine B.V. Senior Management Changes: Christopher Bath Appointed COO
15 Jun 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.